Episode Details
Back to EpisodesSwiss Re’s Kelly: How Behavioral Science Is Key to Potential of GLP-1 Medications
Published 1 year, 6 months ago
Description
Natalie Kelly, head of life & health global underwriting, Swiss Re, explains why long-term health benefits from blood sugar regulators also depend on sustained behavior change, personalized underwriting and the strategic use of behavioral science.